Thirty Years of Sweat Chloride Testing at One Referral Center.

Alethéa Guimarães Faria, Fernando Augusto Lima Marson, Carla Cristina Souza Gomez, Maria de Fátima Servidoni, Antônio Fernando Ribeiro, José Dirceu Ribeiro
Author Information
  1. Alethéa Guimarães Faria: Department of Pediatrics, School of Medical Sciences, University of Campinas, Campinas, Brazil.
  2. Fernando Augusto Lima Marson: Department of Pediatrics, School of Medical Sciences, University of Campinas, Campinas, Brazil.
  3. Carla Cristina Souza Gomez: Department of Pediatrics, School of Medical Sciences, University of Campinas, Campinas, Brazil.
  4. Maria de Fátima Servidoni: Department of Pediatrics, School of Medical Sciences, University of Campinas, Campinas, Brazil.
  5. Antônio Fernando Ribeiro: Department of Pediatrics, School of Medical Sciences, University of Campinas, Campinas, Brazil.
  6. José Dirceu Ribeiro: Department of Pediatrics, School of Medical Sciences, University of Campinas, Campinas, Brazil.

Abstract

OBJECTIVE: To conduct a descriptive analysis of the sweat test (ST), associating ST results with epidemiological data, (cystic fibrosis transmembrane conductance regulator) mutations and reasons to indicate the ST, as well as correlating sweat sodium and sweat chloride concentrations in subjects.
METHODS: Retrospective survey and descriptive analysis of 5,721 ST at a university referral center.
RESULTS: The inclusion of the subjects was based on clinical data related with cystic fibrosis (CF) phenotype. The samples were grouped by (i) sweat chloride concentrations (mEq/L): <30: 3,249/5,277 (61.6%); ≥30 to <60: 1,326/5,277 (25.1%); ≥60: 702/5,277 (13.3%) and (ii) age: (Group A--GA) 0 to <6 months; (Group B--GB) ≥6 months to <18 years; (Group C--GC) ≥18 years. Digestive symptoms showed higher prevalence ratio for the CF diagnosis as well as association between younger age and higher values of sweat chloride, sweat sodium, and chloride/sodium ratio. The indication of ST due to respiratory symptoms was higher in GB and associated with greater age, lower values of sweat chloride, sweat sodium, and chloride/sodium ratio. There was higher prevalence of ST with sweat chloride levels <30 mEq/L in GB, ≥60 mEq/L in GC, and with borderline level in GB. There was positive correlation between sweat sodium and sweat chloride. Sweat chloride/sweat sodium and sweat sodium-sweat chloride indexes showed association with sex, reason for ST indication, and mutations. Sex alters some values presented in the ST. The number of ST/year performed before and after the newborn screening implementation was the same; however, we observed a higher number of borderlines values. A wide spectrum of mutation was found. Severe mutations and F508del/F508del genotype were associated with highest probability of ST chloride levels ≥60 mEq/L, and the absence of mutations identified was associated with borderline ST and respiratory symptoms.
CONCLUSIONS: ST data showed wide variability dependent on age, sex, reason for examination indication, mutations, and weight of the collected sweat sample. Sweat sodium concentration is directly correlated with sweat chloride levels and it could be used as a quality parameter.

Keywords

References

  1. Clin Biochem. 2016 May;49(7-8):601-5 [PMID: 26851350]
  2. J Cyst Fibros. 2011 Jun;10 Suppl 2:S86-102 [PMID: 21658649]
  3. Chest. 2013 Jan;143(1):14-18 [PMID: 23276841]
  4. J Pediatr. 2017 Feb;181S:S33-S44.e2 [PMID: 28129810]
  5. Curr Drug Targets. 2015 ;16(9):1007-17 [PMID: 25438972]
  6. J Pediatr. 2007 Jul;151(1):85-9 [PMID: 17586196]
  7. Pediatrics. 1959 Mar;23(3):545-9 [PMID: 13633369]
  8. Pediatr Pulmonol. 2014 Feb;49(2):106-17 [PMID: 24249707]
  9. J Pediatr. 2017 Feb;181S:S16-S26 [PMID: 28129808]
  10. Curr Gastroenterol Rep. 2004 Jun;6(3):231-9 [PMID: 15128491]
  11. PLoS One. 2012;7(10):e47708 [PMID: 23082198]
  12. Eur J Pediatr. 2015 Dec;174(12):1613-20 [PMID: 26074372]
  13. J Cyst Fibros. 2014 May;13 Suppl 1:S23-42 [PMID: 24856775]
  14. Lancet Respir Med. 2016 Aug;4(8):e37-e38 [PMID: 27377414]
  15. Pediatr Pulmonol. 2014 Dec 30;:null [PMID: 25641878]
  16. BMC Pulm Med. 2014 Dec 13;14:198 [PMID: 25495771]
  17. Rev Port Pneumol (2006). 2017 Jul - Aug;23 (4):227-230 [PMID: 28038996]
  18. Pediatr Res. 1987 Sep;22(3):271-6 [PMID: 2889182]
  19. Dis Markers. 2015;2015:306825 [PMID: 25667564]
  20. Front Pharmacol. 2017 Jun 20;8:390 [PMID: 28676762]
  21. J Pediatr (Rio J). 2010 Mar-Apr;86(2):109-14 [PMID: 20148237]
  22. Acta Paediatr. 2015 May;104(5):e210-5 [PMID: 25640976]
  23. J Bras Pneumol. 2017 Mar-Apr;43(2):121-128 [PMID: 28538779]
  24. J Pediatr. 2015 Jun;166(6):1469-74.e1-3 [PMID: 25812778]
  25. J Pediatr. 2008 Aug;153(2):S4-S14 [PMID: 18639722]
  26. Am J Respir Crit Care Med. 2012 Oct 15;186(8):732-9 [PMID: 22859523]
  27. Pediatrics. 2007 Feb;119(2):e495-518 [PMID: 17272609]
  28. Gene. 2014 May 1;540(2):183-90 [PMID: 24583165]
  29. Clin Microbiol Rev. 2002 Apr;15(2):194-222 [PMID: 11932230]
  30. Diagn Pathol. 2013 Mar 19;8:46 [PMID: 23510227]
  31. Diagn Pathol. 2016 Oct 26;11(1):103 [PMID: 27784314]
  32. Clin Chest Med. 2007 Jun;28(2):319-30 [PMID: 17467551]
  33. Ann N Y Acad Sci. 2010 Dec;1214:57-69 [PMID: 21175684]
  34. J Cyst Fibros. 2014 Mar;13(2):139-47 [PMID: 24660233]
  35. Pediatr Pulmonol. 2017 Sep;52(9):1135-1141 [PMID: 28586522]
  36. J Pediatr (Rio J). 2002 Nov-Dec;78 Suppl 2:S171-86 [PMID: 14676856]
  37. J Cyst Fibros. 2014 Jan;13(1):10-4 [PMID: 23916616]
  38. BMC Gastroenterol. 2013 May 20;13:91 [PMID: 23688510]
  39. Clin Chim Acta. 2008 Jul 17;393(2):128-9 [PMID: 18373980]
  40. Biochem Med (Zagreb). 2017 Feb 15;27(1):122-130 [PMID: 28392735]
  41. J Pediatr. 2017 Feb;181S:S4-S15.e1 [PMID: 28129811]
  42. J Cyst Fibros. 2008 May;7(3):179-96 [PMID: 18456578]

Word Cloud

Created with Highcharts 10.0.0sweatSTchloridesodiummutationshighervaluesdatacysticfibrosis277GroupsymptomsshowedratioageindicationGBassociatedlevelsSweatdescriptiveanalysistestwellconcentrationssubjectsCFprevalencediagnosisassociationchloride/sodiumrespiratory≥60 mEq/LborderlinesexreasonnumberwideOBJECTIVE:conductassociatingresultsepidemiologicaltransmembraneconductanceregulatorreasonsindicatecorrelatingMETHODS:Retrospectivesurvey5721universityreferralcenterRESULTS:inclusionbasedclinicalrelatedphenotypesamplesgroupedmEq/L:<30:3249/5616%≥30<60:1326/5251%≥60:702/5133%iiage:A--GA0<6 monthsB--GB≥6 months<18 yearsC--GC≥18 yearsDigestiveyoungerduegreaterlower<30 mEq/LGClevelpositivecorrelationchloride/sweatsodium-sweatindexesSexalterspresentedST/yearperformednewbornscreeningimplementationhoweverobservedborderlinesspectrummutationfoundSevereF508del/F508delgenotypehighestprobabilityabsenceidentifiedCONCLUSIONS:variabilitydependentexaminationweightcollectedsampleconcentrationdirectlycorrelatedusedqualityparameterThirtyYearsChlorideTestingOneReferralCenter

Similar Articles

Cited By